TC BioPharm reports progress in AML treatment trial
PLC (NASDAQ: TCBP), a biotechnology firm with a market capitalization of $33.08 million engaged in developing gamma-delta T cell therapies, announced today significant progress in its ACHIEVE Phase 2B ...
INmune Bio's CORDStrom shows promise in RDEB treatment
BOCA RATON, FLORIDA - INmune Bio , Inc. (NASDAQ: NASDAQ:INMB), a clinical-stage biotechnology company with a market capitalization of $212.74 million, announced today its plans to submit regulatory ...
Pharmabiz4 小时
CStone Pharma announces inclusion of Cejemly as a first-line combination therapy for NSCLC ...
CStone Pharma announces inclusion of Cejemly as a first-line combination therapy for NSCLC in ESMO guideline: Suzhou, China Tuesday, February 11, 2025, 13:00 Hrs [IST] CStone Phar ...
Nkarta, Inc. (NASDAQ:NKTX) Receives Consensus Recommendation of “Buy” from Analysts
Shares of Nkarta, Inc. (NASDAQ:NKTX – Get Free Report) have been assigned a consensus rating of “Buy” from the seven ...
Opinion
The Conway Daily Sun15 小时Opinion
William Marvel: Fading Faith
Pullquote: Clearly, Carl's aim in sliding his pet project into the budget is to deprive voters of any chance of ever turning it down again, as they have in two ...
Opinion
The Conway Daily Sun15 小时Opinion
Tele-Talk responses: Where should the skateboard park be located?
The effort to build a skateboard park on a piece of land owned by the state at the southern end of the Mount Washington Valley Rec Path has been stymied ...